Herantis Pharma Oyj (HEL:HRTIS)
Finland · Delayed Price · Currency is EUR 1.640
+0.010 (0.61%)
Jul 25, 2025, 5:28 PM EET
Herantis Pharma Oyj Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
11
Market Cap
39.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orion Oyj | 1.68B |
| Terveystalo Oyj | 1.32B |
| Revenio Group Oyj | 106.32M |
| Pihlajalinna Oyj | 707.22M |
| Oriola Oyj | 1.81B |
| Nightingale Health Oyj | 4.95M |
| Aiforia Technologies Oyj | 2.85M |
| Nexstim | 10.21M |